Martine A Rothblatt

Chairperson & CEO · United Therapeutics

Martine A Rothblatt (Chairperson & CEO) filed 187 Form 4 reports in the trailing twelve months (0 purchases, 187 sales, 1 filed past the two-business-day deadline), most often in United Therapeutics Corporation (UTHR). The largest single filing was $10.9M of UTHR (18,840 sh across 15 lots, as filed), executed Apr 14. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

187

0 buys · 187 sells · 1 late

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$889.0M

shares × price, as filed

Last traded

Nov 5

Filed Nov 6

Median ADV $265.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $989.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 187 filings

Sector per market data · by filing · past 12 months

Most traded names

UTHR

United Therapeutics Corporation UTHR · 0 buys · 210 sells 210 filings

Recent filings

UTHRSALE United Therapeutics Corporation View filing → $4.8M
9,000 sh across 13 lots
Exec Oct 6
Filed Oct 7 · 4:35 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.1M
9,500 sh across 11 lots
Exec Oct 5
Filed Oct 6 · 4:32 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.7M
8,500 sh across 12 lots
Exec Oct 2
Filed Oct 5 · 4:53 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.2M
9,046 sh across 15 lots
Exec Oct 1
Filed Oct 2 · 4:31 PM ET